Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +35.94%
#3 Fabric Protocol Fabric Protocol +24.29%
#4 Nockchain Nockchain +24.07%
#5 Bedrock Bedrock +18.12%
#6 Cysic Cysic +15.83%
#7 Perle Perle +12.14%
#8 The Black Bull The Black Bull +9.40%
#9 Anvil Anvil +6.20%
#10 Arowana Arowana +6.03%
Coin of the day
EXOD EXOD
設定
言語
日本
通貨
USD
テーマ
Peak Bio, Inc. Peak Bio, Inc.

Peak Bio, Inc.

PKBO
株式のランク #37553
Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical... Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical development phase, committed to devising treatments for critical, unmet medical needs in the realms of oncology and inflammatory disorders. The company harnesses its unique, proprietary toxin—known as PH-1 or Thailanstatin—a spliceosome modulator, to create its inaugural range of innovative Antibody-Drug Conjugate (ADC) therapies designed for cancer patients facing significant challenges. Additionally, Peak Bio's leading investigational drug, PHP-303, a small molecule, is on the verge of commencing a Phase II dose clinical trial for the rare condition Alpha1 anti-trypsin deficiency (AATD). The company's operations are situated in Palo Alto, California.
株価
$0.07
最終同期: 2024-11-12
時価総額
$1.62M
変化（1日）
0.00%
変化（1年）
0.00%
国
US
取引 Peak Bio, Inc. (PKBO)

カテゴリー

Healthcare
Peak Bio, Inc.（PKBO）の配当利回りの履歴
Peak Bio, Inc.（銘柄コード: PKBO）の配当利回り（TTM）は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
Peak Bio, Inc.（PKBO）の2026から2026までの配当利回りの履歴
各年末時点の配当利回り（TTM）
年 配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り（TTM）
企業 配当利回り 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
0.65%
BE